BeStock  
Stocks › Biotechnology › OMER

Omeros OMER

US equityMarket cap rank #3176Biotechnology
$13.21 −$0.80 (-5.71%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $13.19 -0.15%
Open$13.78
Prev close$14.01
Day range$13.07 – $13.88
Volume2.02M
Market cap$983.66M
P/E (TTM)8.5
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership51.4%+0.60 pts vs. prior quarter
Institutions holding205+7 vs. prior quarter
Insider trades (recent)35 buys / 11 sellsNet buying
Short interest17.73% of floatDays to cover 9.6 · as of 30 Oct 2026
Short-sale volume share24.4%5-day average of daily volume

Short-sale volume as % of daily volume

13%23%33%43%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$742.3K (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

+$314.8KSuper+$427.5KBig−$345.2KMid−$1.9MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 24.9% of shares outstanding.

Largest holders

  • BlackRock8.35%
  • Ingalls & Snyder, LLC5.06%
  • Vanguard Capital Management, LLC4.22%
  • UBS Asset Management4.18%
  • State Street Global Advisors3.10%
  • Geode Capital Management, LLC2.62%
  • Stifel Asset Management Corp.2.54%
  • Gregory Demopulos2.03%

By investor type

  • Mutual Fund43.00%
  • Hedge Fund4.56%
  • Individual/Insider4.29%
  • Public Company2.12%
  • Private Company0.83%
  • Insurance Company0.38%
  • Government Pension Fund0.32%
  • Structured Finance Pool Manager0.09%

Reported short interest has fallen from 20.22% to 17.73% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Federated Hermes, Inc. Mutual Fund 2026/Q3 +556,636 1.4%
Morgan Stanley Public Company 2026/Q3 +409,543 1.1%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +409,543 1.1%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +225,104 0.4%
Virtus Investment Advisers, LLC Mutual Fund 2026/Q3 +59,830 0.3%
Barclays PLC Public Company 2026/Q3 +54,312 0.1%
ProFund Advisors LLC Mutual Fund 2026/Q3 +54,297 0.1%
Driehaus Capital Management LLC Mutual Fund 2026/Q3 +59,413 0.1%
Joseph Schocken Individual/Insider 2026/Q3 +528,082 0.7%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +155,630 0.2%
UBS Asset Management Mutual Fund 2026/Q3 +860,468 4.4%
BlackRock Mutual Fund 2026/Q3 +735,007 8.4%
Rock Springs Capital Management LP Hedge Fund 2026/Q3 +718,499 1.0%
Rubric Capital Management LP Hedge Fund 2026/Q3 +656,874 0.9%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +583,874 1.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
27 Oct 2026 Gregory Demopulos Chairperson & CEO Other Derivative Acquisition +500,000 $17.88 500,000
22 Sep 2026 David Borges VP of Finance, Chief Accounting Officer & Treasurer Derivative Exercise and Sale -20,000 $20.95 –
30 Aug 2026 Peter Cancelmo General Counsel Derivative Exercise and Sale -50,000 $18.65 200
26 Aug 2026 Arnold Hanish Independent Director Derivative Exercise and Sale -15,000 $19.02 12,400
23 Aug 2026 David Borges VP of Finance, Chief Accounting Officer & Treasurer Derivative Exercise and Sale -10,906 $19.10 –
19 Aug 2026 Thomas Cable Lead Independent Director Derivative Exercise and Sale -15,000 $18.45 35,067
12 Aug 2026 David Borges VP of Finance, Chief Accounting Officer & Treasurer Derivative Exercise and Sale -5,000 $16.95 –
11 Aug 2026 Joseph Schocken Director Other Derivative Acquisition +30,000 $13.71 30,000
11 Aug 2026 Joseph Schocken Director Initial Statement of Beneficial +0 – 528,082
21 Jul 2026 Gregory Demopulos Chairperson & CEO Other Derivative Acquisition +1,000,000 $9.84 1,000,000
21 Jul 2026 Peter Cancelmo General Counsel Other Derivative Acquisition +105,000 $9.84 105,000
21 Jul 2026 David Borges VP of Finance, Chief Accounting Officer & Treasurer Other Derivative Acquisition +105,000 $9.84 105,000
17 Jun 2026 Thomas Cable Lead Independent Director Other Derivative Acquisition +15,000 $10.28 15,000
17 Jun 2026 Leroy Hood Independent Director Other Derivative Acquisition +15,000 $10.28 15,000
17 Jun 2026 Arnold Hanish Independent Director Other Derivative Acquisition +15,000 $10.28 15,000
17 Jun 2026 Peter Demopulos Director Other Derivative Acquisition +15,000 $10.28 15,000
17 Jun 2026 Thomas Bumol Independent Director Other Derivative Acquisition +15,000 $10.28 15,000
17 Jun 2026 Rajiv Shah Independent Director Other Derivative Acquisition +15,000 $10.28 15,000
17 Jun 2026 Diana Perkinson Independent Director Other Derivative Acquisition +15,000 $10.28 15,000
21 May 2026 Thomas Cable Lead Independent Director Derivative Exercise and Sale -7,500 $11.61 35,067

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 12,833,757 17.7% 9.6
15 Oct 2026 11,428,767 15.8% 12.2
30 Sep 2026 11,382,531 15.7% 7.0
15 Sep 2026 12,491,576 17.3% 9.3
31 Aug 2026 12,758,406 17.6% 7.3
14 Aug 2026 14,639,133 20.2% 4.9

Discussion

No comments yet — be the first to weigh in on OMER.

Sign in to join the discussion.

Scroll to Top